loading

Galera Therapeutics Inc Azioni (GRTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi
Research and Development
19.42%
6.093
7.561 7.272
Interest Income/Expense
147.44%
-2.087
4.399 4.223
Operating Income/Loss
20.30%
-13.40
-16.81 -13.88
Income/Loss From Continuing Operations Before Tax
27.23%
-15.07
-20.71 -17.71
Income/Loss From Continuing Operations After Tax
27.23%
-15.07
-20.71 -17.71
Net Income/Loss
27.23%
-15.07
-20.71 -17.71
Preferred Stock Dividends And Other Adjustments
-
- -
Attributable To Noncontrolling Interest
-
- -
Basic Average Shares
5.97%
45.48
42.92 35.20
Diluted Average Shares
5.97%
45.48
42.92 35.20
Basic Earnings Per Share
31.25%
-0.33
-0.48 -0.50
Diluted Earnings Per Share
168.75%
-0.33
0.48 -0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- -
$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
Capitalizzazione:     |  Volume (24 ore):